Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125304781 | 12530478 | 1 | I | 2000 | 20160610 | 20160706 | 20160706 | PER | US-SHIRE-US201607178 | SHIRE | 0.00 | M | Y | 97.51000 | KG | 20160706 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125304781 | 12530478 | 1 | PS | PENTASA | MESALAMINE | 1 | Oral | 2000 MG (FOUR 500 MG), 2X/DAY:BID (IN AM AND IN PM) | 20049 | 2000 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125304781 | 12530478 | 1 | Crohn's disease |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125304781 | 12530478 | Ill-defined disorder | |
125304781 | 12530478 | Product use issue | |
125304781 | 12530478 | Restlessness | |
125304781 | 12530478 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125304781 | 12530478 | 1 | 2000 | 0 |